Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

SP ? 4.8mm WN, SLActive? 12mm, TiZr, NTP: medical device reports filed with FDA

1,205 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,205
device reports naming the brand
0% of all MAUDE reports · about 176 a year
169
reports, 12 months to August 2026
163 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,205 reports that name the brand "SP ? 4.8mm WN, SLActive? 12mm, TiZr, NTP" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

169 reports arrived in the 12 months to August 2026, close to the 163 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (53%), loss of osseointegration (33.4%) and difficult to insert (1.7%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02142Sep 2021: 15Oct 2021: 15Nov 2021: 11Dec 2021: 102022Jan 2022: 8Feb 2022: 11Mar 2022: 12Apr 2022: 9May 2022: 21Jun 2022: 11Jul 2022: 19Aug 2022: 13Sep 2022: 13Oct 2022: 23Nov 2022: 15Dec 2022: 182023Jan 2023: 20Feb 2023: 11Mar 2023: 14Apr 2023: 9May 2023: 14Jun 2023: 18Jul 2023: 10Aug 2023: 11Sep 2023: 11Oct 2023: 13Nov 2023: 15Dec 2023: 192024Jan 2024: 12Feb 2024: 18Mar 2024: 10Apr 2024: 25May 2024: 18Jun 2024: 10Jul 2024: 8Aug 2024: 9Sep 2024: 7Oct 2024: 15Nov 2024: 12Dec 2024: 152025Jan 2025: 11Feb 2025: 13Mar 2025: 11Apr 2025: 8May 2025: 0Jun 2025: 42Jul 2025: 16Aug 2025: 13Sep 2025: 8Oct 2025: 15Nov 2025: 12Dec 2025: 162026Jan 2026: 17Feb 2026: 11Mar 2026: 13Apr 2026: 13May 2026: 17Jun 2026: 9Jul 2026: 20Aug 2026: 18

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0871732019: 12820192020: 13620202021: 16120212022: 17320222023: 16520232024: 15920242025: 16520252026: 1182026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,205
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report86.7%1,045
Voluntary report0%0
User facility report0%0
Distributor report13.3%160
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate63953%62.8%
Loss of osseointegration40233.4%22.4%
Difficult to insertthe device was hard to insert201.7%0.4%
Difficult to removethe device was hard to remove30.2%0%
Separation failure20.2%0.1%
Unintended movement20.2%0%
Fracturea broken bone10.1%1.6%
Positioning problem10.1%0.1%
Unstable10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis38732.1%
Painpain, site not specified24220.1%
Tissue damage18415.3%
Inflammationinflammation786.5%
Hemorrhage/blood loss/bleeding574.7%
Swelling/ edema564.6%
Abscessa collection of pus403.3%
Hyperresponsive to stimuli282.3%
Fistula161.3%
Inadequate osseointegration131.1%
Failure of implant110.9%
Hypersensitivity/allergic reaction110.9%
Swellingswelling100.8%
Sinus perforation50.4%
Increased sensitivity40.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSP ? 4.8mm WN, SLActive? 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports1,2053,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer86.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about SP ? 4.8mm WN, SLActive? 12mm, TiZr, NTP reports

How many FDA reports name SP ? 4.8mm WN, SLActive? 12mm, TiZr, NTP?

1,205 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 169 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (53%), loss of osseointegration (33.4%), difficult to insert (1.7%), difficult to remove (0.2%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (86.7%) and distributor reports (13.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that SP ? 4.8mm WN, SLActive? 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.